Anti-human Osteocalcin MAb (Clone OR06)
Osteocalcin is classified as a Bone/Growth Biomarker.
Classification of primary osteoporosis (low or high remodeling).
Systematic follow-up of osteoporosis treatment.
Associated with PTH, assessment of renal osteodystrophy.
Evaluation of osteoblastic activity for patients under prolonged corticosteroid therapy.
Our proprietary rat monoclonal antibody (IgG1) is used in IVD kits and for Research purposes.